ArticleNPJ digital medicine2025
Physics-informed machine learning digital twin for reconstructing prostate cancer tumor growth via PSA tests.
Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Cancer Heterogeneity and Cancer Cell Plasticity: Molecular Mechanisms and Precision Therapy.MedComm · 2026Review
- Digital twin technologies in prostate cancer as a frontier for precision medicine.European radiology experimental · 2026Review
- [Digital twins in uro-oncology].Urologie (Heidelberg, Germany) · 2026Review
- Digital twins and digital models of the human circulatory system.Nature reviews bioengineering · 2026Article
- Review
- The future of mathematical oncology in the age of AI.NPJ systems biology and applications · 2026Review
- From images to physics-based computational models to digital twins: a framework for personalized cancer therapies.Frontiers in radiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Existing prostate cancer monitoring methods, reliant on prostate-specific antigen (PSA) measurements in blood tests often fail to detect tumor growth. We develop a computational framework to reconstruct tumor growth from the PSA integrating physics-based modeling and machine learning in digital twins. The physics-based model considers PSA secretion and flux from tissue to blood, depending on local vascularity. This model is enhanced by deep learning, which regulates tumor growth dynamics through the patient's PSA blood tests and 3D spatial interactions of physiological variables of the digital twin. We showcase our framework by reconstructing tumor growth in real patients over 2.5 years from diagnosis, with tumor volume relative errors ranging from 0.8% to 12.28%. Additionally, our results reveal scenarios of tumor growth despite no significant rise in PSA levels. Therefore, our framework serves as a promising tool for prostate cancer monitoring, supporting the advancement of personalized monitoring protocols.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.